InvestorsHub Logo
Followers 4
Posts 589
Boards Moderated 0
Alias Born 03/07/2003

Re: Bio_pete post# 230706

Thursday, 11/28/2019 3:32:17 PM

Thursday, November 28, 2019 3:32:17 PM

Post# of 425942
Even if they show greater bio availability they will need an outcomes trial to claim CVD risk improvement. That’s a whole lot of money and a whole lot of years away from competing with Vascepa. There is no coattail effect available for them. You want the label you run the outcomes trial on a large scale for a lot of years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News